Marvell Technology Stock Rally Faces Key Test as FirstQuarter Earnings Approach Alibaba Advances AI Ambitions with Enhanced Zhenwu Chip and New Large Language Model John McEnroes Criticism of Alexander Zverev Could Shape Tennis Stars Brand Perception Genpact CEO Warns AI Will Reduce IT Workload and Jobs Cites Shift in Hiring Trends American Global Secures Lloyds Quota Share Reinsurance Deal Expanding Underwriting Capacity JPMorgans Summer Reading List for Affluent Clients Highlights AI Leadership and Unexpected Titles ACXP Q1 2026 Earnings Narrowed Loss Surprises as Acurx Advances Lead Candidate LONA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism FNV Q1 2026 Earnings EPS Surpasses Estimates by 137 as Royalty Portfolio Delivers Rallybio Corporation Q1 2026 Earnings Wider Loss Reflects RD Investment Stock Gains GLP Q1 2026 Earnings Massive EPS Beat Surprises Markets Amid Revenue Discretion CVGI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Aurora Innovation Inc AUR Edges Lower as Key Support Level Approaches CocaCola Consolidated COKE Faces Resistance as Shares Pull Back 223 Pool Corporation POOL Faces Headwinds as Shares Slip Below 183 Corebridge Financial Junior Subordinated Notes CRBD Nudge Lower Amid Steady FixedIncome Sentiment Carlisle Companies CSL Gains 15 as Building Products Sector Shows Momentum United Homes Group Warrant UHGWW Holds Steady at 023 as Trading Range Narrows DEFSEC Technologies DFSC Faces Selling Pressure as Shares Slip Below Key Levels NewMarket Corp NEU Gains 221 as Stock Approaches Key Resistance Levels Eaton Vance Enhanced Equity Income Fund II EOS Hovers Near Support Amid Low Volatility Zions Bancorporation ZION Edges Higher as Regional Banking Sentiment Stabilizes Nuveen Core Equity Alpha Fund JCE Inches Higher Near Key Resistance Level Disney Shares Surge 7 After Streaming and Parks Drive Revenue Beat in First Earnings Report Under CEO Josh DAmaro Mainz Biomed NV Ordinary Shares Q4 2023 Earnings EPS Beat Estimate Despite Absence of Revenue Stock Declines Assembly Biosciences ASMB Slides 386 as Biotech Sector Faces Headwinds